MétaCan
Menu
Back to cohort
Record W4413903871 · doi:10.1016/j.jaip.2025.08.021

Response to Biologics Along a Gradient of T2 Involvement in Patients With Severe Asthma: A Data-Driven Biomarker Clustering Approach

2025· article· en· W4413903871 on OpenAlexafffund
Eileen Wang, William Henley, Désirée Larenas‐Linnemann, Lakmini Bulathsinhala, Trung N. Tran, Michael E. Wechsler, Shawn D. Aaron, Mona Al‐Ahmad, Riyad Al‐Lehebi, Alan Altraja, Peter Barker, Aaron Beastall, А. S. Belevskiy, Céline Bergeron, Leif Bjermer, Unnur Steina Björnsdóttir, Sinthia Bosnic‐Anticevich, Arnaud Bourdin, Guy Brusselle, John Busby, Giorgio Walter Canonica, Victoria Carter, Kenneth R. Chapman, Nicholas Chapman, George Christoff, Borja G. Cosío, Richard W. Costello, James Fingleton, João Fonseca, Mina Gaga, Peter G. Gibson, Susanne Hansen, Liam G. Heaney, Enrico Heffler, Mark Hew, Takahiko Horiguchi, Flavia Hoyte, Richard Hubbard, Takashi Iwanaga, David J. Jackson, Rohit Katial, Mariko Siyue Koh, Κonstantinos Κostikas, Piotr Kuna, Sverre Lehmann, Lauri Lehtimäki, Renaud Louis, Dóra Lúðvíksdóttir, Njira Lugogo, Bassam Mahboub, Neil A. Martin, Jorge Máspero, Andrew Menzies‐Gow, Arjun Mohan, Ruth Murray, Tatsuya Nagano, Nikolaos G. Papadopoulos, Andriana Ι. Papaioannou, Pujan H. Patel, Luis Pérez de Llano, Diahn‐Warng Perng, Matthew Peters, Paul Pfeffer, Paulo Márcio Pitrez, Roy A. Pleasants, Todor A. Popov, Celeste Porsbjerg, Francesca Puggioni, Anna Quinton, Chin Kook Rhee, Mohsen Sadatsafavi, Sundeep Salvi, Giulia Scioscia, Chau‐Chyun Sheu, Concetta Sirena, Camille Taillé, Christian Taube, Carlos A. Torres‐Duque, Ming‐Ju Tsai, Alf Tunsäter, Charlotte Suppli Ulrik, David Price

Bibliographic record

VenueThe Journal of Allergy and Clinical Immunology In Practice · 2025
Typearticle
Languageen
FieldMedicine
TopicAsthma and respiratory diseases
Canadian institutionsUniversity of TorontoVancouver General HospitalVancouver Hospital and Health Sciences CentreUniversity of British ColumbiaOttawa Hospital
FundersEisai CanadaGenentechGrifolsShionogiEisaiSingapore General HospitalGlenmark PharmaceuticalsHorizon TherapeuticsOptimum Patient CareRegeneron PharmaceuticalsInsmedUnited Therapeutics CorporationTeva Pharmaceutical IndustriesGilead SciencesDaiichi Sankyo EuropeSanofiGlaxoSmithKlineAmgenPfizerAstraZenecaEli Lilly and CompanyBristol-Myers Squibb
KeywordsMedicineAsthmaBiomarkerCluster analysisMEDLINEOncologyInternal medicineArtificial intelligence

Abstract

fetched live from OpenAlex

BACKGROUND: Asthma with low levels of type 2 (T2) biomarkers is poorly understood. OBJECTIVE: To characterize severe asthma phenotypes and compare changes in asthma outcomes from pre- to postbiologic treatment along a gradient of T2 involvement. METHODS: This was a registry-based cohort study including data from 24 countries. Biomarker distribution (blood eosinophil count, fractional exhaled nitric oxide, and IgE) was quantified before biologic initiation. Clusters were identified using a 5-component Gaussian finite mixture model and phenotypically characterized. Changes in asthma and health care utilization outcomes between 1-year pre- and postbiologic initiation were compared between clusters and by biologic class. RESULTS: Among 3675 patients, 5 biomarker clusters were identified along a gradient of T2 involvement: cluster A with the lowest T2 involvement (16.4%), cluster B (20.4%), cluster C (22.9%), cluster D (30.3%), and cluster E with the highest T2 involvement (10.0%). In multivariable analysis, biologic use was associated with improved outcomes in all clusters but tended to be better at the higher end of the T2 spectrum. For example, patients in cluster C had a significantly greater increase in forced expiratory volume in 1 second compared with cluster A (difference 0.16 L [95% confidence interval: 0.08, 0.25]; P < .001). The odds of uncontrolled asthma were approximately 0.6 for all clusters compared with cluster A. Overall, exacerbation rates were lower, and greater improvements in lung function and asthma control were noted for anti-IL-5/5 receptor (R) (but not anti-IgE or anti-IL-4Rα) for all clusters compared with cluster A. CONCLUSION: T2-targeting biologics have utility in the management of asthma with low T2 involvement, but more effective therapies are needed. Further research is warranted to identify specific pathogenic pathways at the lower end of the T2 spectrum that can be effectively targeted by biologics.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.006
metaresearch head score (Gemma)0.012
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.010
Threshold uncertainty score0.033

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0060.012
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0030.002
Science and technology studies0.0010.000
Scholarly communication0.0020.000
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.040
GPT teacher head0.348
Teacher spread0.308 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueThe Journal of Allergy and Clinical Immunology In PracticeSame topicAsthma and respiratory diseasesFrench-language works237,207